Xiao-hong Zhao

Prevalence of monoclonal gammopathy of uncertain significance in chronic myeloid leukemia

Shi-yun Lu, W. Ouyang, Xiao-hong Zhao, 2018, Medicine.

Responses to Dasatinib as a Second- and Third-Line Tyrosine Kinase Inhibitor in Chronic Phase Chronic Myeloid Leukaemia Patients

J. Cen, Qinrong Wang, Jinlan Pan, 2019, Acta Haematologica.

Prolyl oligopeptidase inhibitor suppresses the upregulation of ACSDKP in patients with acute myeloid leukemia.

Shi-yun Lu, Xiao-hong Zhao, Z. Wang, 2018, Experimental and therapeutic medicine.

CD86 +1057G/A polymorphism and risk of chronic immune thrombocytopenia

Shi-yun Lu, Pin Wu, Xiao-hong Zhao, 2014, Autoimmunity.

Aptamers in hematological malignancies and their potential therapeutic implications.

Zi-qiang Yu, W. Ouyang, Xiao-hong Zhao, 2016, Critical reviews in oncology/hematology.